Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Hope for arthritis stems from within

next article
31.01.2006

 


Leeds bioengineers have developed an innovative technique for cartilage repair combining the self-healing powers of the body with stem cell science to help young people avoid debilitating knee problems and give hope to arthritis sufferers.

Current treatments of cartilage defects in the knee are expensive, have lengthy recovery times, and can even cause as much damage as good. “We’re responding to a real need,” said reader in bioengineering Dr Bahaa Seedhom.


“Orthopaedic surgeons are looking for ways to repair cartilage defects in young people which will delay, maybe even prevent, the need for total knee replacement.”

The bioengineers have invented a repair technique – and tools – that cut surgery times from two hours to ten minutes, and can have patients back on their feet within three weeks. The treatment involves a surgical technique called subchondral drilling, where holes are drilled into the bone beneath the cartilage in the damaged site, causing bleeding from the bone marrow, which stimulates stem cells to grow tissue within the damaged area. Surgeons then implant a felt-like pad, to encourage the cells to expand and grow into tissue.

As the treatment uses the body’s own stem cells, it is much cheaper than existing methods, where tissue is engineered outside the body and then implanted. The system has potential for widescale applications. “Initially young people with small defects will be most suitable for treatment, but once the system has been put through its paces it might well be used for larger defects in older arthritic patients,” said Dr Seedhom.

Dr Seedhom is joined on the project by Drs Toyoda, Luo, Lorrison and Michael Pullan from bioengineering. The arthritis research campaign has awarded the project £131,000 to explain the cartilage regeneration process, and Smith and Nephew have begun an evaluation programme to commercialise the technology for clinical use within four years.

Claire Jones | Source: alphagalileo
Further information: www.leeds.ac.uk/medicine/musculoskeletal/bioengeneering.html
reporter.leeds.ac.uk/513/s2.htm

next article

More articles from Life Sciences:

nachricht Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | NOAA Fisheries Northeast Fisheries Science Center

nachricht Texas A&M Researchers Examine How Viruses Destroy Bacteria
20.11.2009 | Texas A&M University

All articles from Life Sciences >>>

B2B Search

Product / Service
Company / Organisation

Latest News

Scientists Unravel Evolution of Highly Toxic Box Jellyfish

20.11.2009 | Life Sciences

When good companies do bad things: Examining illegal corporate behavior

20.11.2009 | Business and Finance

UCR plant scientist's research spawns new discoveries showing how crops survive drought

20.11.2009 | Agricultural and Forestry Science

VideoLinks

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News